Table 2 Nutritional characteristics, values given as mean (s.d.), unless stated otherwise

From: The impact of body composition parameters on ipilimumab toxicity and survival in patients with metastatic melanoma

Characteristic

Males ( n =52)

Females ( n =32)

Total ( n =84)

BMI (kg m−2), median (IQR)

27.6 (24.9–30.1)

26.5 (23.3–29.5)

26.9 (24.4–30.4)

Underweight (⩽18.5 kg m−2), n (%)

0 (0)

2 (6.3)

2 (2)

Normal (18.5–24.9 kg m−2), n (%)

13 (25)

10 (31)

23 (28)

Overweight (25–29.9 kg m−2) n (%)

24 (46)

14 (44)

38 (45)

Obese (⩾30.0 kg m−2), n (%)

15 (29)

6 (19)

21 (25)

Skeletal muscle area (cm2)

174.7 (32.1)

114.3 (13.3)

151.6 (39.6)

Skeletal muscle index (cm2 m−2)

56.4 (9.6)

43.4 (5.2)

51.4 (10.4)

Sarcopenia, n (%)

10 (19.2)

10 (31.3)

20 (23.8)

Muscle attenuationa (HU)

39.8 (7.9)

38.8 (10.2)

39.4 (8.9)

Low muscle attenuationa, n (%)

12 (27.9)

12 (41.4)

24 (33.3)

Adipose tissue area (cm2)

401.3 (182.5)

259.4 (133.6)

350.2 (179.2)

Adipose tissue index (cm2 m−2)

129.0 (57.5)

98.8 (50.4)

118.2 (56.6)

Estimated FFM (kg)

58.5 (9.6)

40.3 (4.0)

51.6 (11.9)

Estimated FM (kg)

28.1 (7.7)

22.1 (5.6)

25.9 (7.5)

  1. Abbreviations: BMI=body mass index; CT=computed tomography; FM=fat mass; FFM=fat-free mass; HU=Hounsfield units; IQR=interquartile range; MA=muscle attenuation; s.d.=standard deviation.
  2. aMA assessed for 72 patients (43 men and 29 women). Twelve patients (3 women and 9 men) lacked suitable contrast-enhanced CT images for MA analysis.
Back to article page